Impact of Oral Antibiotic Treatment for Chronic Endometritis on Pregnancy Outcomes in the Following Frozen-Thawed Embryo Transfer Cycles of Infertile Women: a Cohort Study of 640 Embryo Transfer Cycles.

Yujing Xiong,Qi Chen,Chunxiao Chen,Jinfeng Tan,Zengyan Wang,Fang Gu,Yanwen Xu
DOI: https://doi.org/10.1016/j.fertnstert.2021.03.036
IF: 6.7
2021-01-01
Fertility and Sterility
Abstract:Objective: To investigate the therapeutic effect of antibiotic treatment on pregnancy outcomes in the following frozen-thawed embryo transfer cycles of infertile women. Design: Retrospective study. Setting: University assisted reproduction unit. Patient(s): A total of 640 women were included. Among them, the number of CD138+ cells per high-power field (CD138+/HPF) in the endometrium at the first evaluation was 0 in 88 women; 315 women had 1-4 CD138+/HPF and the remaining 237 had >5 CD138+/ HPF. Finally, 26 of 237 women had persistent chronic endometritis (PCE) diagnosed. Intervention(s): Hysteroscopy and endometrial biopsy were performed in the proliferative phase. After antibiotic treatment, endometrial biopsy samples were collected again. Main Outcome Measure(s): Live birth rate. Result(s): No significant difference in pregnancy outcomes was found between women with CD138+/HPF = 0 and those with CD138+/HPF 1-4. The cure rate was 89.0% in women with CD138+/HPF >5 after treatment. The implantation rate (51.6% vs. 32.3%, relative risk [RR] 2.23, 95% confidence interval [CI] 1.07-4.66), clinical pregnancy rate (65.7% vs. 42.3%, RR 2.62, 95% CI 1.17-5.86), live birth rate (52.1% vs. 30.7%, RR 2.45, 95% CI 1.04-5.76), and cumulative live birth rate (64.2% vs. 38.5%, RR 2.88, 95% CI 1.27-6.51) were all significantly higher in women with CD138+/HPF <4 than in women with PCE. Conclusion(s): CD138+/HPF <4 in the endometrium had no negative impact on pregnancy outcomes. Antibiotic treatment was an effective way to improve the reproductive outcomes of women with CD138+/HPF >5. PCE was associated with poorer pregnancy outcomes. (Fertil Sterile 2021;116:413-21. (c) 2021 by American Society for Reproductive Medicine.)
What problem does this paper attempt to address?